Interpregnancy Interval After Healthy Live Birth and Subsequent Spontaneous Abortion.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
03 Jun 2024
Historique:
medline: 17 6 2024
pubmed: 17 6 2024
entrez: 17 6 2024
Statut: epublish

Résumé

Many studies have reported that the interpregnancy interval (IPI) is a potential modifiable risk factor for adverse perinatal outcomes. However, the association between IPI after live birth and subsequent spontaneous abortion (SA) is unclear. To investigate the association of IPI after a healthy live birth and subsequent SA. This prospective cohort study used data from 180 921 women aged 20 to 49 years who had a single healthy live birth and planned for another pregnancy and who participated in the Chinese National Free Prepregnancy Checkups Project from January 1, 2010, to December 31, 2020. Statistical analysis was conducted from June 20 to October 5, 2023. Interpregnancy interval, defined as the interval between the delivery date and conception of the subsequent pregnancy, was categorized as follows: less than 18 months, 18 to 23 months, 24 to 35 months, 36 to 59 months, and 60 months or longer. The main outcome was SA. Multivariable-adjusted odds ratios (ORs) were calculated by logistic regression models to examine the association between IPI and the risk of SA. Dose-response associations were evaluated by restricted cubic splines. The analyses included 180 921 multiparous women (mean [SD] age at current pregnancy, 26.3 [2.8] years); 4380 SA events (2.4% of all participants) were recorded. A J-shaped association between IPI levels and SA was identified. In the fully adjusted model, compared with IPIs of 18 to 23 months, both short (<18 months) and long (≥36 months) IPIs showed an increased risk of SA (IPIs of <18 months: OR, 1.15 [95% CI, 1.04-1.27]; IPIs of 36-59 months: OR, 1.28 [95% CI, 1.15-1.43]; IPIs of ≥60 months: OR, 2.13 [95% CI, 1.78-2.56]). Results of the subgroup analysis by mode of previous delivery were consistent with the main analysis. This cohort study of multiparous women suggests that an IPI of shorter than 18 months or an IPI of 36 months or longer after a healthy live birth was associated with an increased risk of subsequent SA. The findings are valuable to make a rational prepregnancy plan and may facilitate the prevention of SA and improvement in neonatal outcomes.

Identifiants

pubmed: 38884995
pii: 2820088
doi: 10.1001/jamanetworkopen.2024.17397
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2417397

Auteurs

Xuan Hu (X)

National Research Institute for Family Planning, Beijing, China.
Department of Epidemiology and Health Statistics, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu, China.
National Human Genetic Resources Center, Beijing, China.

Ying Yang (Y)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.
Graduate School of Peking Union Medical College, Beijing, China.

Long Wang (L)

Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, China.

Chuanyu Zhao (C)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.
Graduate School of Peking Union Medical College, Beijing, China.

Xinyi Lyu (X)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.
Graduate School of Peking Union Medical College, Beijing, China.

Meiya Liu (M)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.

Hanbin Wu (H)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.

Jueming Lei (J)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.

Jiaxin Li (J)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.
Graduate School of Peking Union Medical College, Beijing, China.

Mengxin Yao (M)

Department of Epidemiology and Health Statistics, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu, China.

Yaling Ding (Y)

Department of Epidemiology and Health Statistics, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu, China.

Hongguang Zhang (H)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.

Yuan He (Y)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.
Graduate School of Peking Union Medical College, Beijing, China.

Yuanyuan Wang (Y)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.
Graduate School of Peking Union Medical College, Beijing, China.

Zuoqi Peng (Z)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.

Haiping Shen (H)

Department of Maternal and Child Health, National Health Commission of the People's Republic of China, Beijing, China.

Qiaomei Wang (Q)

Department of Maternal and Child Health, National Health Commission of the People's Republic of China, Beijing, China.

Yiping Zhang (Y)

Department of Maternal and Child Health, National Health Commission of the People's Republic of China, Beijing, China.

Donghai Yan (D)

Department of Maternal and Child Health, National Health Commission of the People's Republic of China, Beijing, China.

Jieyun Yin (J)

Department of Epidemiology and Health Statistics, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu, China.
Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non-communicable Diseases, Soochow University, Jiangsu, China.
MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China.

Xu Ma (X)

National Research Institute for Family Planning, Beijing, China.
National Human Genetic Resources Center, Beijing, China.
Graduate School of Peking Union Medical College, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH